Experimental combo shows promise in Hard-to-Treat cancers
NCT ID NCT05001347
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug (TJ004309) combined with an approved immunotherapy (atezolizumab) in 25 people with advanced ovarian, head and neck, lung, gastrointestinal, or triple-negative breast cancers. The goal was to see if the combination could shrink tumors. Participants had cancers that stopped responding to standard treatments. The study is complete, and results help guide future research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arizona Oncology Associates
Tucson, Arizona, 85711, United States
-
Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Illinois Cancer Specialists
Arlington Heights, Illinois, 60005, United States
-
Innovative Clinical Research Institute
Whittier, California, 90603, United States
-
Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York, 10016, United States
-
Maryland Oncology Hematology
Rockville, Maryland, 20850, United States
-
Medical Oncology Hematology Consultants, PA
Newark, Delaware, 19713, United States
-
Northwest Cancer Specialists
Vancouver, Washington, 98684, United States
-
Texas Oncology - Arlington North
Arlington, Texas, 76012, United States
-
Texas Oncology - Austin Central
Austin, Texas, 78731, United States
-
Texas Oncology - Forth Worth Cancer Center
Fort Worth, Texas, 76104, United States
-
Texas Oncology - The Woodlands, Gynecologic Oncology
The Woodlands, Texas, 77380, United States
-
Tri County Hematology and Oncology Associates
Massillon, Ohio, 44646, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
-
Women's Cancer Care
Covington, Louisiana, 70433, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital peer support: a new weapon against cancer treatment anxiety?
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Can targeted radiation boost Immunotherapy's power against head and neck cancer?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?